Consumer use of the internet for medicines information

Peterson-Clark, G; Aslani, P; Williams, KA

Consumer use of the internet for medicines information

Peterson-Clark, G Aslani, P Williams, KA

Permalink

Publication Type:: Journal Article
Citation:: International Journal of Pharmacy Practice, 2004, 12 (4), pp. 185 - 190
Issue Date:: 2004-12-01

Closed Access

	Filename	Description	Size
	2010004355OK.pdf		114.74 kB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Peterson-Clark, G	en_US
dc.contributor.author	Aslani, P	en_US
dc.contributor.author	Williams, KA https://orcid.org/0000-0002-5094-243X	en_US
dc.date.issued	2004-12-01	en_US
dc.identifier.citation	International Journal of Pharmacy Practice, 2004, 12 (4), pp. 185 - 190	en_US
dc.identifier.issn	0961-7671	en_US
dc.identifier.uri	http://hdl.handle.net/10453/21975
dc.description.abstract	Objective: To explore consumer opinion of the internet as a source of medicines information, the reasons consumers use this information, and the impact of this information on their use of medicines. Method: Focus groups (n = 6) were conducted in metropolitan Sydney, Australia during March to May 2003 with consumers (n = 46) who had used the internet for medicines information. Key findings: Although participants expressed some concerns about the quality of internet-based medicines information (IBMI), the convenience of access to this information outweighed these reservations. Attitudes were thus positive overall. Participants used IBMI when preparing for doctors' visits, for second opinions and additional information, for information on current issues, when deciding whether to use a medicine, for comparative information on brands and generics, and when written information was not supplied by health professionals. Most participants felt empowered by the information they found and used it to play a more active role in decision making about their therapy. Conclusion: This study describes various issues associated with consumer use of IBMI and highlights the possible role of pharmacists to support their patients' efforts to access and interpret medicines information.	en_US
dc.relation.ispartof	International Journal of Pharmacy Practice	en_US
dc.relation.isbasedon	10.1211/0022357044562	en_US
dc.subject.classification	Pharmacology & Pharmacy	en_US
dc.title	Consumer use of the internet for medicines information	en_US
dc.type	Journal Article
utslib.citation.volume	4	en_US
utslib.citation.volume	12	en_US
utslib.for	1115 Pharmacology and Pharmaceutical Sciences	en_US
dc.location.activity	WOS:000287161100006
pubs.embargo.period	Not known	en_US
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Graduate School of Health
pubs.organisational-group	/University of Technology Sydney/Strength - CHSP - Health Services and Practice
utslib.copyright.status	closed_access
pubs.issue	4	en_US
pubs.publication-status	Published	en_US
pubs.volume	12	en_US

Abstract:

Objective: To explore consumer opinion of the internet as a source of medicines information, the reasons consumers use this information, and the impact of this information on their use of medicines. Method: Focus groups (n = 6) were conducted in metropolitan Sydney, Australia during March to May 2003 with consumers (n = 46) who had used the internet for medicines information. Key findings: Although participants expressed some concerns about the quality of internet-based medicines information (IBMI), the convenience of access to this information outweighed these reservations. Attitudes were thus positive overall. Participants used IBMI when preparing for doctors' visits, for second opinions and additional information, for information on current issues, when deciding whether to use a medicine, for comparative information on brands and generics, and when written information was not supplied by health professionals. Most participants felt empowered by the information they found and used it to play a more active role in decision making about their therapy. Conclusion: This study describes various issues associated with consumer use of IBMI and highlights the possible role of pharmacists to support their patients' efforts to access and interpret medicines information.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/21975